NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email A look at the New York Fed’s Economic Heterogeneity Indicators (EHIs), which have been expanded to include the performance of small businesses.Read More